investors trivascular.com

Investors - TriVascular Technologies Inc.

The Investor Relations website contains information about TriVascular Technologies Inc. business for stockholders, potential investors, and financial analysts.

OVERVIEW

This website investors.trivascular.com presently has a traffic ranking of zero (the smaller the better). We have evaluated nineteen pages inside the web page investors.trivascular.com and found three websites referencing investors.trivascular.com. I unearthed two public communication accounts linked to investors.trivascular.com.
Pages Analyzed
19
Links to this site
3
Social Links
2

INVESTORS.TRIVASCULAR.COM RANKINGS

This website investors.trivascular.com is seeing diverging quantities of traffic within the past the year.
Traffic for investors.trivascular.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investors.trivascular.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investors.trivascular.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO BUSINESS

Homepage Trivascular

Abdominal Stent Graft Platform is FDA-approved to treat the widest range of anatomies with an innovative, less invasive, clinically proven solution for patients with aortic disease. With the Ovation platform, the polymer-filled sealing rings create a custom seal and protect the aortic neck.

TriVascular

Instructions for Use, Indications, Contraindications, and Caution Statement.

WHAT DOES INVESTORS.TRIVASCULAR.COM LOOK LIKE?

Desktop Screenshot of investors.trivascular.com Mobile Screenshot of investors.trivascular.com Tablet Screenshot of investors.trivascular.com

INVESTORS.TRIVASCULAR.COM HOST

I caught that the main page on investors.trivascular.com took one thousand one hundred and ninety-nine milliseconds to download. We could not discover a SSL certificate, so our parsers consider this site not secure.
Load time
1.199 seconds
SSL
NOT SECURE
Internet Address
206.200.251.19

TITLE

Investors - TriVascular Technologies Inc.

DESCRIPTION

The Investor Relations website contains information about TriVascular Technologies Inc. business for stockholders, potential investors, and financial analysts.

CONTENT

This website states the following, "Reports Second Quarter Financial Results." Our analyzers viewed that the web page said " Receives FDA Approval of the Ovation iXTM Abdominal Stent Graft System." The Website also said " View all press releases . Aug 12, 2015 at 800 AM ET. Aug 4, 2015 at 130 PM PT. TRIV 2Q15 Earnings Conference Call. View all events and presentations . Instructions for Use, Indications, Contraindications, and Caution Statement."

SUBSEQUENT WEB PAGES

Lektorat German as a Foreign Language

Lektorat German as a Foreign Language. Juli bis Freitag, 1. Wenn Sie nicht persönlich kommen können, finden Sie Informationen hier. A to Z for Students.